Vaxcyte Ownership | Who Owns Vaxcyte?

Overview ForecastFinancials Chart Transcripts

Vaxcyte Ownership Summary

Vaxcyte is owned by 29.09% institutional investors, 0.64% insiders, and 70.27% retail investors. Fmr is the largest institutional shareholder, holding 9.20% of PCVX shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.97% of its assets in Vaxcyte shares.

PCVX Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Vaxcyte	29.09%	0.64%	70.27%
Sector	Healthcare Stocks	41.88%	10.83%	47.29%
Industry	Biotech Stocks	44.05%	10.78%	45.17%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Fmr	12.51M	9.20%	$450.61M
Vanguard group	12.32M	9.06%	$443.78M
Ra capital management	11.97M	8.80%	$431.01M
Janus henderson group	10.58M	8.55%	$865.61M
Blackrock	9.94M	8.48%	$750.56M
Blackrock funding, inc. /de	9.96M	7.32%	$358.61M
T. rowe price investment management	8.32M	6.11%	$299.52M
Wellington management group llp	5.03M	3.70%	$181.28M
State street	4.79M	3.52%	$172.39M
Paradigm biocapital advisors lp	3.78M	2.78%	$136.33M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Pivotal bioventure partners investment advisor	1.37M	28.58%	$49.43M
Kynam capital management, lp	3.07M	8.24%	$110.64M
Saturn v capital management	788.44K	6.23%	$28.40M
Ra capital management	11.97M	5.31%	$431.01M
Paradigm biocapital advisors lp	3.78M	3.88%	$136.33M
Ghost tree capital	150.00K	3.55%	$11.33M
Eversept partners, lp	1.42M	3.53%	$51.22M
Deep track capital, lp	3.00M	3.02%	$108.06M
Novo	916.16K	2.13%	$33.00M
Logos global management lp	625.00K	2.02%	$22.51M

Top Buyers

Holder	Shares	% Assets	Change
T. rowe price investment management	8.32M	0.18%	2.31M
Norges bank	1.10M	0.01%	1.10M
Deep track capital, lp	3.00M	3.02%	850.00K
Point72 asset management	696.84K	0.04%	696.84K
Westfield capital management co lp	3.73M	0.56%	663.82K

Top Sellers

Holder	Shares	% Assets	Change
Capital research global investors	842.98K	0.01%	-3.93M
Darwin global management	-	-	-2.20M
Commodore capital lp	-	-	-1.65M
Price t rowe associates inc /md/	1.69M	0.01%	-1.48M
Avoro capital advisors	-	-	-1.00M

New Positions

Holder	Shares	% Assets	Change	Value
Norges bank	1.10M	0.01%	1.10M	$90.07M
Logos global management lp	625.00K	2.02%	625.00K	$22.51M
Adage capital partners gp	333.00K	0.02%	333.00K	$11.99M
Healthcare of ontario pension plan trust fund	134.88K	0.01%	134.88K	$4.86M
Hrt financial lp	114.03K	0.02%	114.03K	$4.11M

Sold Out

Holder	Change
Dinuzzo private wealth	-1.00
Jfs wealth advisors	-1.00
Global financial private client	-1.00
Mai capital management	-2.00
Capital performance advisors llp	-3.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2025	123	-58.16%	39,571,115	-72.00%	29	0.27%	52	-71.58%	52	-29.73%
Jun 30, 2025	302	-7.93%	147,482,023	1.73%	108	0.95%	183	-2.66%	77	-20.62%
Mar 31, 2025	35	-89.64%	28,246,930	-79.94%	20	0.16%	20	-90.10%	6	-93.02%
Dec 31, 2024	130	-62.54%	38,665,990	-71.44%	31	0.26%	83	-61.03%	32	-63.64%
Sep 30, 2024	344	25.09%	135,391,305	10.49%	109	1.00%	210	32.08%	88	18.92%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	3.86M	2.97%	-80.72K
Vanguard US Total Market Shares ETF	3.67M	2.85%	587.74K
iShares Russell 2000 ETF	3.02M	2.33%	-
Vanguard Small Cap Index	2.98M	2.29%	-19.86K
Vanguard Health Care Inv	2.83M	2.20%	-1.03M
Janus Inst Mid Cap Growth CF	2.64M	2.05%	1.26M
Janus Henderson Enterprise D	2.64M	2.04%	-
Janus Concentrated Growth CF	2.16M	1.67%	-
Janus Henderson Forty S	2.16M	1.66%	-
SPDR® S&P Biotech ETF	2.01M	1.55%	4.49K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Mar 05, 2025	Eydelman Mikhail	SVP, GEN COUNSEL & CORP SEC	Sell	$8.11K
Mar 05, 2025	Eydelman Mikhail	SVP, GEN COUNSEL & CORP SEC	Sell	$184.49K
Mar 05, 2025	Eydelman Mikhail	SVP, GEN COUNSEL & CORP SEC	Sell	$161.11K
Mar 03, 2025	Wassil Jim	CHIEF OPERATING OFFICER	Sell	$153.95K
Mar 03, 2025	Wassil Jim	CHIEF OPERATING OFFICER	Sell	$432.21K

Insider Transactions Trends

Date	Buy	Sell
2025 Q3	-	-
2025 Q2	-	-
2025 Q1	-	32
2024 Q4	-	68
2024 Q3	-	54

PCVX Ownership FAQ

Who Owns Vaxcyte?

Vaxcyte shareholders are primarily institutional investors at 29.09%, followed by 0.64% insiders and 70.27% retail investors. The average institutional ownership in Vaxcyte's industry, Biotech Stocks , is 44.05%, which Vaxcyte falls below.

Who owns the most shares of Vaxcyte?

Vaxcyte’s largest shareholders are Fmr (12.51M shares, 9.20%), Vanguard group (12.32M shares, 9.06%), and Ra capital management (11.97M shares, 8.80%). Together, they hold 27.05% of Vaxcyte’s total shares outstanding.

Does Blackrock own Vaxcyte?

Yes, BlackRock owns 8.48% of Vaxcyte, totaling 9.94M shares as of Jun 2024. This represents 0.02% of BlackRock's total assets, with a market value of 750.56M$. In the last quarter, BlackRock increased its holdings by 426.84K shares, a 4.49% change.

Who is Vaxcyte’s biggest shareholder by percentage of total assets invested?

Pivotal bioventure partners investment advisor is Vaxcyte’s biggest shareholder by percentage of total assets invested, with 28.58% of its assets in 1.37M Vaxcyte shares, valued at 49.43M$.

Who is the top mutual fund holder of Vaxcyte shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Vaxcyte shares, with 2.97% of its total shares outstanding invested in 3.86M Vaxcyte shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools